EMG
VRTX icon

ETF Managers Group’s Vertex Pharmaceuticals VRTX Stock Holding History

ETF Managers Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$5.96M Buy
18,918
+16,194
+594% +$4.86M 0.19% 95
2022
Q4 		$787K Sell
2,724
-2,847
-51% -$868K 0.04% 193
2022
Q3 		$1.61M Sell
5,571
-663
-11% -$191K 0.05% 168
2022
Q2 		$1.75M Buy
6,234
+3,000
+93% +$803K 0.05% 176
2022
Q1 		$830K Buy
3,234
+56
+2% +$13.3K 0.02% 334
2021
Q4 		$707K Buy
3,178
+150
+5% +$29.2K 0.01% 429
2021
Q3 		$552K Buy
3,028
+234
+8% +$45.7K 0.01% 512
2021
Q2 		$550K Buy
2,794
+1,455
+109% +$304K 0.01% 522
2021
Q1 		$285K Buy
1,339
+175
+15% +$38.4K 0.01% 593
2020
Q4 		$271K Sell
1,164
-1,457
-56% -$334K 0.01% 560
2020
Q3 		$708K Sell
2,621
-1,092
-29% -$301K 0.02% 252
2020
Q2 		$1.06M Buy
+3,713
New +$1.01M 0.04% 174
2019
Q2 		– Sell
-877
Closed -$161K – 661
2019
Q1 		$161K Buy
877
+73
+9% +$13.5K 0.01% 368
2018
Q4 		$133K Buy
804
+120
+18% +$20.8K 0.01% 371
2018
Q3 		$132K Buy
684
+72
+12% +$12.8K 0.01% 338
2018
Q2 		$72K Sell
612
-30
-5% -$4.65K 0.01% 341
2018
Q1 		$100K Buy
642
+80
+14% +$13.1K 0.01% 282
2017
Q4 		$86K Buy
562
+80
+17% +$11.8K 0.01% 263
2017
Q3 		$73K Buy
482
+40
+9% +$6.02K 0.01% 158
2017
Q2 		$57K Buy
+442
New +$53.2K ﹤0.01% 235
2016
Q1 		$33K Buy
+298
New +$27K 0.02% 277

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ETF Managers Group's VRTX Position: Q1 2023 in Review

ETF Managers Group increased its Vertex Pharmaceuticals (VRTX) stake by 594% in Q1 2023, buying an estimated $4.86M and bringing the position to 18,918 shares worth $5.96M. The position accounts for 0.19% of the portfolio, ranked #95.

ETF Managers Group first reported a position in VRTX in Q1 2016 and has held it in 21 quarters since. 1,208 funds tracked by Wall St. Rank hold VRTX as of Q1 2023.

  • ETF Managers Group held 18,918 shares of Vertex Pharmaceuticals worth $5.96M as of Q1 2023.
  • ETF Managers Group bought 16,194 Vertex Pharmaceuticals shares in Q1 2023, an estimated $4.86M.
  • Vertex Pharmaceuticals made up 0.19% of ETF Managers Group's portfolio in Q1 2023, its #95 holding.
  • ETF Managers Group first reported a position in Vertex Pharmaceuticals in Q1 2016 and has held it in 21 quarters since.
  • 1,208 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.